1,2-Dichloroethane → HCID 178481252, 화합물
반응식
[C:1]([CH:5]1[CH2:10][CH2:9][CH:8]([N:11]([CH2:22][C:23]2[CH:31]=[CH:30][C:26]([C:27](O)=[O:28])=[CH:25][CH:24]=2)[C:12]2[N:16]([CH3:17])[C:15]3[CH:18]=[CH:19][CH:20]=[CH:21][C:14]=3[N:13]=2)[CH2:7][CH2:6]1)([CH3:4])([CH3:3])[CH3:2].O.[NH:33]1[C:37]([NH2:38])=[N:36][N:35]=[N:34]1.C1C=CC2N(O)N=NC=2C=1.C(Cl)CCl.CCN(C(C)C)C(C)C>CN(C=O)C>[C:1]([CH:5]1[CH2:10][CH2:9][CH:8]([N:11]([CH2:22][C:23]2[CH:31]=[CH:30][C:26]([C:27]([NH:38][C:37]3[NH:36][N:35]=[N:34][N:33]=3)=[O:28])=[CH:25][CH:24]=2)[C:12]2[N:16]([CH3:17])[C:15]3[CH:18]=[CH:19][CH:20]=[CH:21][C:14]=3[N:13]=2)[CH2:7][CH2:6]1)([CH3:4])([CH3:3])[CH3:2]참가 물질
반응물 5
생성물 1
시약·촉매·용매 1
실험 절차
To a solution of the product of Example 5 Step A (0.14 mmol, 64 mg), 1H-tetraazol-5-amine monohydrate (0.28 mmol, 29 mg), HOBt (0.35 mmol, 53 mg) and EDC (0.56 mmol, 108 mg) in 1 mL of DMF was added DIEA (0.7 mmol, 122 μL). The reaction was allowed to stand at ambient temperature for 21 h, then concentrated under reduced pressure. The residue was taken up in ca. 2:1 dioxane/H2O and acidified with TFA, then purified by reverse-phase chromatography (Condition A). The product was lyophilized, affording a white solid. 1H NMR (500 MHz, CD3OD): δ 8.01 (d, 2H), 7.52-7.62 (overlapping m, 3H), 7.35-7.50 (overlapping m, 3H), 3.87 (s, 3H), 3.76 (m, 1H), 2.16 (m, 2H), 1.99 (m, 2H), 1.84 (m, 2H), 1.30 (m, 2H), 1.14 (m, 1H), 0.92 (s, 9H). MS (ESI): m/z 487 (M+H). HPLC A: 1.97 min.
후처리
- concentrationconcentrated under reduced pressure
- custompurified by reverse-phase chromatography (Condition A)
- customaffording a white solid
- custom1.97 min.
출처 및 근거
- ORD 기록
- ord-4a942c6766c94bff86cb744fa3a7a2b1
- 출처 데이터셋
- uspto-grants-2009_07
- 특허 번호
- US07563815B2
반응 노트
불러오는 중…